Literature DB >> 8417499

Function and regulation of the human multidrug resistance gene.

K V Chin1, I Pastan, M M Gottesman.   

Abstract

The discovery of an energy-dependent pump system for natural product anticancer drugs has important implications for the biology of related energy-dependent transport systems as well as for the treatment of human cancer. To fully realize the therapeutic potential associated with manipulation of the multidrug transporter, it will be necessary to understand the mechanisms of action of the transporter and its mode of regulation. This review has summarized recent developments in these areas which suggest that both the activity of the pump and its genetic regulation are potential targets for new anticancer therapies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417499     DOI: 10.1016/s0065-230x(08)60825-8

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  26 in total

1.  Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1.

Authors:  P C Brown; J A Silverman
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

2.  Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors.

Authors:  A Krautheim; P Brechlin; K Becker; M Winkler; H J Steinfelder
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  New chemosensitivity test using a thermo-reversible gelation polymer for recurrent gynecologic cancer patients and a preliminary study of mechanisms of anticancer drug resistance.

Authors:  Tatsuru Ohara; Kazushige Kiguchi; Satoshi Tsukikawa; Sojiro Sato; Yoichi Kobayashi; Bunpei Ishizuka; Sunao Kubota
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

Review 4.  Characterization and functional reconstitution of the multidrug transporter.

Authors:  F J Sharom
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

Review 5.  Molecular analysis of the multidrug transporter.

Authors:  U A Germann
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 6.  Topoisomerase I in multiple drug resistance.

Authors:  A Pessina
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Ribozyme-mediated reversal of the multidrug-resistant phenotype.

Authors:  K J Scanlon; H Ishida; M Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.

Authors:  W Walther; U Stein
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 9.  Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.

Authors:  R Radinsky
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

10.  Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.

Authors:  Ying Huang; Paul E Blower; Ruqing Liu; Zunyan Dai; Anh-Nhan Pham; Hojin Moon; Jialong Fang; Wolfgang Sadée
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.